The presence of amyloid plaques, sticky substances in the brain, is a hallmark of Alzheimer’s disease — though the role it plays is a matter of debate among neurologists. The FDA has approved ...

Creatine is breaking out of the gym and stepping into clinical neuroscience. With early research pointing to cognitive benefits in Alzheimer’s patients, its potential is impossible to ignore.

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

Joe Walsh, 79, is waiting to inhale. He's perched on a tan recliner at the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital in Boston. His wife, Karen Walsh, hovers over ...

New data reveals more than 7 million Americans are currently living with Alzheimer’s – a first in U.S. history. Experts warn this number is projected to nearly double, reaching an estimated 14 ...

The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease or related forms of dementia, according to new research.

June is Alzheimer's and Brain Awareness Month. More than 7 million Americans ages 65 and older are living with Alzheimer’s disease right now.

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find ...

Alzheimer's disease affects millions of people around the world and occurs when abnormal proteins build up in the brain, leading to the death of brain cells and declines in cognitive function and ...